Solara Active Pharma Sciences Publishes Rights Share Call Advertisement

1 min read     Updated on 25 Mar 2026, 09:14 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Solara Active Pharma Sciences has published newspaper advertisements in Business Standard and Pratahkal on March 25, 2026, informing shareholders about the second and final call of ₹112.50 per rights share. The company set April 2, 2026, as the record date for determining eligible shareholders, with proper regulatory filings made to BSE and NSE under SEBI compliance requirements.

powered bylight_fuzz_icon
35874627

*this image is generated using AI for illustrative purposes only.

Rights Issue Committee Decision

Solara Active Pharma Sciences Limited has announced the publication of newspaper advertisements regarding the second and final call on partly-paid rights shares, following the Rights Issue Committee meeting held on March 24, 2026. The pharmaceutical company published advertisements in Business Standard and Pratahkal newspapers on March 25, 2026, informing shareholders about the call details and record date.

Call Amount Structure

The committee has determined a comprehensive call amount structure for the partly-paid rights shares:

Component: Amount per Share
Face Value: ₹3.00
Securities Premium: ₹109.50
Total Call Amount: ₹112.50

Record Date and Process Details

Key details of the rights share call process have been established:

Parameter: Details
Record Date: Thursday, April 2, 2026
Purpose: Determining holders of partly paid-up equity shares
Action: Call notices dispatch to eligible shareholders
Basis: Rights shares under May 9, 2024 Letter of Offer
Website Publication: https://solara.co.in/investor-relations/newspaper-publications

Stock Exchange Communication

The formal announcement was communicated to both major stock exchanges where the company's shares are listed:

Exchange: Details
BSE Limited: Scrip Code 541540, Symbol SOLARA
NSE India Limited: Scrip Code 890202, Symbol SOLARAPP1
Compliance: Regulation 30 and 42 of SEBI LODR 2015
Filing Date: March 25, 2026

Corporate Governance and Compliance

The intimation was signed by Pooja Jaya Kumar, Company Secretary and Compliance Officer (ICSI Membership No. A57415), ensuring adherence to corporate governance protocols. The communication included detailed regulatory disclosures as required under SEBI guidelines, with the newspaper advertisements being made available on the company's official website for investor reference.

Share Transfer Window Notice

The company has also announced a special window for re-lodgement of transfer requests for physical shares, running from February 5, 2026, to February 4, 2027. This facility is available for shareholders whose transfer requests were rejected or returned due to document deficiencies before March 31, 2021, in compliance with SEBI circular requirements.

How will the ₹112.50 per share call amount impact Solara's cash flow and capital structure once fully collected?

What strategic initiatives or expansion plans does Solara intend to fund with the capital raised from this rights issue completion?

Will the completion of this rights issue affect Solara's debt-to-equity ratio and overall financial leverage in the pharmaceutical sector?

Solara Active Pharma Sciences Completes Postal Ballot for Director Appointment

2 min read     Updated on 10 Mar 2026, 03:50 PM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Solara Active Pharma Sciences Limited completed its postal ballot process for appointing Mr. Mohanraj Sanjeevi as Whole-time Director, receiving overwhelming shareholder support with 99.97% votes in favor. The appointment is for three years with a comprehensive remuneration package of Rs. 1,00,00,000 annually, conducted through remote e-voting with 58.64% participation from outstanding shares.

powered bylight_fuzz_icon
34673696

*this image is generated using AI for illustrative purposes only.

Solara Active Pharma Sciences Limited has successfully completed its postal ballot process for the appointment of Mr. Mohanraj Sanjeevi (DIN: 08420411) as Whole-time Director (Executive Director). The company formally communicated the voting results to BSE Limited and National Stock Exchange of India Limited on March 10, 2026, pursuant to Regulation 44 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015.

Overwhelming Shareholder Support

The postal ballot results demonstrate exceptional shareholder confidence in the appointment, with the special resolution passed with requisite majority on March 06, 2026.

Voting Results: Details
Total Votes in Favor: 26,032,102 (99.97%)
Total Votes Against: 7,752 (0.03%)
Total Valid Votes: 26,039,854
Voting Participation: 58.64% of outstanding shares
Members Voting in Favor: 273
Members Voting Against: 24

Category-wise Voting Pattern

The resolution received unanimous support from promoter and institutional categories, with minimal dissent from public non-institutional shareholders.

Shareholder Category: Shares Held Votes Polled % Participation Votes in Favor % Support
Promoter and Promoter Group: 18,156,624 16,804,568 92.55% 16,804,568 100.00%
Public-Institutions: 7,056,216 5,815,768 82.42% 5,815,768 100.00%
Public-Non-institutions: 19,189,763 3,419,518 17.82% 3,411,766 99.77%

Official Compliance and Documentation

The scrutinizer's report was prepared by Preetnam Hebbar & Co., Company Secretaries, confirming the validity of the postal ballot process conducted entirely through remote e-voting in compliance with MCA General Circulars.

Compliance Details: Information
Total Shareholders on Record: 71,749
Cut-off Date: January 30, 2026
Scrutinizer: Preetnam Hebbar & Co.
E-voting Platform: Central Depository Services (India) Limited

Appointment Details and Remuneration

Mr. Mohanraj Sanjeevi has been appointed as Whole-time Director for a period of three years, effective from January 01, 2026, to December 31, 2028, with a comprehensive remuneration package.

Remuneration Component: Amount/Details
Fixed Remuneration: Rs. 85,00,000 per annum
Variable Pay: Rs. 15,00,000 per annum
Total Annual Package: Rs. 1,00,00,000
Annual Increment: Up to 30% of last drawn remuneration

Additional benefits include insurance and social security benefits, encashment of un-availed earned leave, business travel expense reimbursements, company-sponsored car and driver for business purposes, ESOP grants, and corporate credit card facility as approved by the Board.

Voting Process Timeline

The postal ballot was conducted entirely through remote e-voting in compliance with regulatory requirements, with Central Depository Services (India) Limited providing the e-voting platform.

Process Timeline: Details
Notice Dispatch: February 04, 2026
E-voting Commencement: February 05, 2026, 9:00 AM
E-voting Conclusion: March 06, 2026, 5:00 PM
Result Declaration: March 06, 2026
Stock Exchange Filing: March 10, 2026

More News on Solara Active Pharma Sciences - PP